HLA-DRB1 and rheumatoid arthritis: CVD mortality has been associated with level of inflammation, HLA–DRB1*0404 [10], use of glucocorticoids [24] and presence of RA autoantibodies [25, 26], and can possibly be reduced by effective RA treatments [27, 28].